MENU
AURA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aura Biosciences (AURA) Ownership - Who owns Aura Biosciences?
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer... Show more
Profile
Industry
N/A
Address
80 Guest Street
Phone
+1 617 500-8864
Employees
89
Web
https://www.aurabiosciences.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
421.63M
P/E Ratio
N/A
Total Cash
127.99M
Projected Growth
N/A
Total Debt
18.44M
Revenue
N/A
Risk (Beta)
0.14
Dividend Yield
N/A
Total Cash/Share
2.06
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AURA
Capitalization
422M
P/E Ratio
N/A
Risk (Beta)
0.14
Dividend Yield
N/A
Total Cash
128M
Total Cash/Share
2.06
Total Debt
18.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
128M
P/B Ratio
3.29
Cash Flow
N/A
Earnings
-1.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
11.06
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-101.63M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.51
Shares Held By Institutions
288M
Shares Outstanding - Current
62M
Total Liabilities
27.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-17.275
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AURA showed earnings on May 15, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
80 Guest Street
Phone
+1 617 500-8864
Employees
89
Web
https://www.aurabiosciences.com